跳至主要内容
临床试验/IRCT201110281556N30
IRCT201110281556N30已完成2 期

The effect of pioglitazone on negative symptoms in patients with chronic schizophrenia: a double blind and placebo controlled trial

Tehran University of Medical Sciences0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 50 years(—)
性别
All

入选标准

  • Inclusion Criteria: age between 18-50 years old; diagnosis of Schizophrenia based on DSM IV; chronic Schizophrenia( duration of the disorder>2 years); minimum Score of 60 on Positive and Negative Scale; being treated with a stable dose of risperidone for at least 8 weeks and clinically stable for at least 4 weeks prior to entry.

排除标准

  • substance dependence; IQ <70; any other mental disorder on axis I; any serious medical or neurological problem; receiving ECT during the last 14 days and hepatic or renal diseases.

研究者

相似试验